StockDocs
Main Newswire Learn
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
CRVW

CareView Communications, Inc.

CRVW OTC Radio & Tv Broadcasting & Communications Equipment EDGAR ↗
$0.04
+0.00 0.00%

Key statistics

from XBRL data in SEC filings
Market cap ⓘ
$23.4M
Revenue (TTM) ⓘ
$9.44M
Net income (TTM) ⓘ
-$2.73M
EPS (TTM) ⓘ
$-0.01
P/E ratio ⓘ
—
Dividend yield ⓘ
—
Free cash flow ⓘ
$797K
Cash ⓘ
$1.92M
Total assets ⓘ
$5.90M
Gross margin ⓘ
—
52-week range ⓘ
$0.01 – $0.08

AI briefing

from the latest 10-K, 10-Q and 8-K events

CareView Communications is an OTCQB-listed provider of turnkey patient video monitoring systems for hospitals, with 2025 revenue of $9.0M and a shareholders' deficit of $43.8M.

What they do

CareView sells modular patient video monitoring systems to hospitals and healthcare facilities, built around the CareView Patient Safety System and CareView Patient Care System. Installations use HD cameras, pan-tilt-zoom, two-way audio/video and LCD displays, and the company states its systems are installed in more than 160 hospitals. Its SitterView and TeleMedView applications let staff observe and communicate with patients remotely, and the company says it holds a portfolio of 40 patents.

Revenue drivers

  • Patient Safety and Patient Care Systems — Modular camera, audio/video and display configurations sold or deployed to hospitals; the company's core offering and the basis for essentially all reported revenue.
  • SitterView remote observation — Software and camera configuration that replaces in-room sitters; the company says it has increased usage in response to remote monitoring demand and staffing shortages.
  • TeleMedView — Remote observation and communication application that runs on the CareView Mobile Controller's built-in monitor and the Portable Controller.

Recent performance

Annual revenue went from $8.3M in 2024 to $9.0M in 2025, while net loss narrowed from $4.7M to $3.2M. Quarterly revenue was $2.1M in Q3 2025, $2.3M in Q4 2025, $2.2M in Q1 2026 and $2.8M in Q2 2026. At June 30, 2026 the company reported total assets of $5.9M, total liabilities of $49.6M, shareholders' deficit of $43.8M and cash of $1.9M. Full-year operating cash flow was positive $805,184 in 2025, following negative $305,029 in 2024.

Strategy

The company positions itself around patient safety outcomes, stating that installations have produced an 80% decrease in patient falls and sitter cost reductions of more than 65%. It emphasizes modular, scalable configurations that fit different facility types, and continued use of its 40-patent portfolio as a differentiator. The filing also notes increased demand for SitterView and TeleMedView tied to healthcare staffing shortages. Since the prior 10-K, the company has announced a series of material agreements and direct financial obligations in 8-K filings dated December 2024 through July 2026, most recently on July 2, 2026.

Risks

  • Negative equity and heavy leverage — At June 30, 2026 liabilities of $49.6M exceeded assets of $5.9M, leaving a $43.8M shareholders' deficit against only $1.9M of cash.
  • Recurring losses — The company has reported annual net losses each year from 2021 through 2025, including $3.2M in 2025.
  • Serial financing obligations — The company has disclosed a recurring pattern of new material agreements and direct financial obligations, including notes payable of $20.0M outstanding on the June 30, 2026 balance sheet, which can dilute or subordinate existing holders.
  • Concentrated, capital-constrained customer base — Revenue of roughly $2-3M per quarter comes from hospital installations, a customer group with long sales cycles and capital budget constraints.

Outlook

The filings provided do not include specific management guidance or a quantified revenue or earnings forecast. The most recent reported data show Q2 2026 revenue of $2.8M, the highest of the last four quarters. Management's stated emphasis remains patient safety outcomes, remote monitoring adoption and modular deployments rather than any new product or market guidance. No forward-looking financial targets can be cited from the excerpts provided.

Recent SEC filings

40 most recent
Annual, quarterly & current reports